After historic acquisition, Coloplast CEO takes stock: "Building up capacity will take a while"
The recent USD 2.5bn acquisition of Atos Medical has been in the works for many years, says President and CEO at Coloplast Kristian Villumsen. With its biggest acquisition ever now behind it, Coloplast is now putting a damper on its acquisition hunt.
by ULRICH QUISTGAARD, translated by daniel pedersen
Now that Coloplast has announced its acquisition of Swedish firm Atcos Medical, there are no more big company purchases in the works at the medtech firm.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast's USD 2.5bn acquisition is its biggest ever
For subscribers
Coloplast acquires Atos Medical for USD 2.5bn
For subscribers
